Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Circulatory System Drugs (Find 15 items)

Circulatory System Drugs

Sitagliptin

(486460-32-6)
Sitagliptin is a new type of anti-type II diabetes drug approved by the FDA and the first dipeptidyl peptidase-IV inhibitor drug used to treat type II diabetes. Sitagliptin's mechanism of action is different from previous oral hypoglycemic drugs. It improves the ability of diabetic patients' own pancreatic β cells to produce insulin and increases insulin secretion when blood sugar rises, thereby controlling the blood sugar level of diabetic patients. Clinical studies have shown that sitagliptin

Product List

News

Request for quotation , get quotes from more suppliers.

Simvastatin

(79902-63-9)
HMG-CoA reductase inhibitors can reduce the concentration of serum total cholesterol and inhibit cholesterol synthesis. It is used for the treatment of primary hypercholesterolemia with other treatments that are ineffective or intolerable, and the cholesterol level exceeds 7.8mmol/L. Has the effect of lowering cholesterol, low-density lipoprotein cholesterol and very low-density lipoprotein cholesterol

Product List

Request for quotation , get quotes from more suppliers.

Sorafenib

(284461-73-0)
A potent RAF kinase inhibitor. Antineoplastic Multiple kinase inhibitor targeting both RAF kinase and receptor tyrosine kinases that promote angiogensis. Antineoplastic. Sorafenib Tosylate (Bay 43-9006, Nexavar) is a small molecular inhibitor of VEGFR, PDGFR, c-Raf and B-Raf with IC50s of 18 nM, 10 nM, 3 nM and 15 nM, respectively. Sorafenib Tosylate (Bay 43-9006) is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively - See more at: http://www.sel

Product List

Request for quotation , get quotes from more suppliers.

Saxagliptin

(361442-04-8)
Saxagliptin is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration and has a pharmacokinetic profile compatible with once daily dosing.

Product List

Request for quotation , get quotes from more suppliers.

Sumatriptan succinate

(103628-48-4)
Sumatriptan (succinate) is a serotonin 5-hydroxytryptamine 1 (5-HT1) receptor agonist with selective affinity for 5-HT1B and 5-HT1D receptors with IC50 values of 9.3 and 7.3 nM, respectively. It also has affinity for the 5-HT1F receptor (IC50 = 17.8 nM). Sumatriptan (succinate) has been shown to induce vasoconstriction of human middle meningeal arteries (EC50 = 89.9 nM) and reduce vascular inflammation associated with migraines.

Product List

Request for quotation , get quotes from more suppliers.

Sparteine

(90-39-1)
It can stimulate the uterus; it can induce labor; it can reduce myocardial stress and conductivity, slow down the heart rate, and suppress the contractility of the heart.

Product List

Request for quotation , get quotes from more suppliers.

Sodium ferulate

(24276-84-4)
For the treatment of coronary heart disease, ischemic encephalopathy, leukocytes and thrombocytopenia

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Sodium nitroprusside dihydrate

(13755-38-9)
Reagent for the detection of many organic Compounds, e.g., acetone, aldehydes, also of alkali sulfides, zinc, SO2.

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

  • 1
  • 2
  • Go to Page Go
Circulatory system drugs are about drugs that have the function of regulating the human circulatory system. The circulatory system is a system of body fluids (including blood, lymph and tissue fluids) and pipes through which circulation flows. Circulatory system drugs mainly include cardiovascular system drugs and diuretics. "Circulatory System Drugs" on ECHEMI covers lipid regulating drugs, angina pectoris drugs, calcium channel blockers, anti-congestive heart failure drugs, antihypertensive drugs, antiarrhythmics drugs, anti shock vasoactive drugs, ace inhibitor, peripheral vasodilators, heart failure treatments and drugs, Anti-atherosclerotic drugs, β-adrenergic receptor blockers and other circulatory system drugs, mainly supply raw materials for such drugs.

Frequently Asked Questions

What are circulatory system drugs used for?

Circulatory system drugs are medications designed to treat conditions affecting the heart and blood vessels. They are commonly used to manage hypertension (high blood pressure), heart failure, arrhythmias, angina, and to prevent blood clots. These drugs help regulate blood flow, reduce cardiac workload, and improve overall cardiovascular function, playing a critical role in both acute and chronic cardiovascular care.

What are the main types of circulatory system medications?

The main types of circulatory system drugs include:1. Antihypertensives (e.g., ACE inhibitors, beta-blockers, calcium channel blockers) for lowering blood pressure.2. Antiarrhythmics to stabilize irregular heart rhythms.3. Vasodilators that widen blood vessels to improve blood flow.4. Anticoagulants and antiplatelets (e.g., warfarin, aspirin) to prevent clot formation.5. Diuretics to reduce fluid buildup and lower blood pressure.Each class targets specific mechanisms within the cardiovascular system to achieve therapeutic effects.

How do I choose a reliable supplier for circulatory system APIs?

To choose a reliable supplier for circulatory system active pharmaceutical ingredients (APIs), consider the following criteria:1. Regulatory compliance—ensure the supplier holds certifications such as GMP, FDA approval, or EMA authorization.2. Quality assurance—verify robust testing protocols, documentation (e.g., COA, DMF), and traceability of raw materials.3. Manufacturing consistency—assess batch-to-batch reproducibility and scalability.4. Technical support and regulatory expertise to assist with global market requirements.Selecting a vetted, experienced API manufacturer minimizes risk and ensures drug safety and efficacy.

What quality standards apply to circulatory system drug intermediates?

Circulatory system drug intermediates must adhere to stringent quality standards to ensure final drug safety and performance. Key standards include compliance with ICH guidelines, GMP (Good Manufacturing Practice), and pharmacopeial specifications (e.g., USP, EP). Impurity profiles, residual solvents, and structural identity must be rigorously controlled. Reputable manufacturers conduct comprehensive analytical testing (HPLC, GC, NMR) and maintain full documentation for regulatory submissions.

Are there common side effects associated with circulatory system medications?

Yes, circulatory system drugs may cause side effects depending on the drug class. For example:- Beta-blockers can lead to fatigue, cold extremities, or bradycardia.- ACE inhibitors may cause a persistent dry cough or hyperkalemia.- Diuretics might result in electrolyte imbalances or dehydration.- Anticoagulants increase bleeding risk.Patients should always use these medications under medical supervision, and healthcare providers monitor for adverse reactions to optimize therapy safety and effectiveness.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.